Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.360
+0.130 (5.83%)
At close: Jul 17, 2026, 4:00 PM EDT
2.350
-0.010 (-0.42%)
After-hours: Jul 17, 2026, 6:05 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $149.52 million as of July 17, 2026. Its market cap has increased by 102.83% in one year.
Market Cap
149.52M
Enterprise Value
123.59M
1-Year Change
102.83%
Ranking
Category
Stock Price
$2.36
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $149.52M, a decrease of -71.45%. That is a compound annual growth rate of -23.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 149.52M | 108.81% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 158.97M |
| PepGen | 154.59M |
| Armata Pharmaceuticals | 153.45M |
| Kazia Therapeutics | 153.12M |
| Connect Biopharma Holdings | 149.22M |
| Molecular Partners AG | 146.99M |
| Unicycive Therapeutics | 146.83M |
| TuHURA Biosciences | 143.92M |